By binding to the Toll-like receptor-4 (TLR-4)–CD14 complex, Lipopolysaccharide (LPS) activates the immune system, interfering with the insulin receptor and leading to an increase in testosterone production resulting in PCOS and insulin resistance [36,37]. This evidence concerns the gene TLR4 and polycystic ovary syndrome.